Crohn’s Disease Treatment Market, By Drugs Type (Anticonvulsants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids (Oxycodones, Hydrocodones, Tramadol, and Others), Antidepressants, and Others), By Application (Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-operative Pain, Cancer Pain, and Others), By Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospitals Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029

Report Code: PMI10218 | Publish Date: March 2024 | No. of Pages: 174

Global Crohns Disease Treatment Market Overview

Crohn\\'s disease is an inflammatory bowel disease (IBD). Crohn\\'s disease leads to the inflammation of digestive tract and can cause severe diarrhea, abdominal pain, malnutrition, and weight loss. 

Frequent research and development activities for development of novel drug for crohn’s disease treatment and increasing launches and approval of new drugs is expected to drastically fuel crohn’s disease treatment market growth. For instance, in 2016, U.S. Food and Drug Administration approved Janssen Biotech, Inc.’s drug STELARA (ustekinumab) indicated for the treatment of moderately to severely active crohn’s disease in adults (18 years or older).

Robustpipeline of crohn’s disease treatment drugs which are expected get approval in near future is also expected to drive the market growth in near future. For instance, Janssen a Johnson & Johnson company has kicked off a Phase II/III programme assessing tremfya in crohn\\'s disease.

Furthermore, high prevalence of disease in key region such as U.S. is expected to increase demand for its treatment and drive market growth. For instance as per the Centers for Disease Control and Prevention in 2015, the rate crohn\\'s disease in U.S. is 3.1 to 14.6 cases per 100,000 person-years.

The crohn’s disease treatment market has been segmented on the basis of drug type, distribution channel, application, and region.

On the basis of applications, the crohn’s disease treatment market has been segmented in antibiotics, amino salicylates, corticosteroids, immunomodulators, and others.

On the basis of application, the crohn’s disease treatment market has been segmented in Neuropathic pain, fibromyalgia, chronic back pain, arthritic pain, migraine post-operative pain, cancer pain, and others.

On the basis of distribution channel, the crohn’s disease treatment market has been segmented in retail pharmacies, online pharmacies and hospitals pharmacies.

On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account major market share as compared to that of other regions.

Key players operating in the Crohn’s Disease Treatment market includes, AbbVie Inc., Janssen Biotech, Inc., BoehringerIngelheim GmbH, Eli Lilly and Company, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Allergan Inc., Pfizer, Inc.,Bayer AG, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche, and Bristol-Myers Squibb.

Global Crohns Disease Treatment Market Table of Contents

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drugs Type
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Opportunity Map Analysis
  3. Market Dynamics Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
      • Drivers- Restraints Impact Analysis
      • PEST Analysis
      • Porter’s Five Forces Analysis
  4. Global Crohn’s Disease Treatment Market, By Drugs Type, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Segment Trends
    • Antibiotics
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Amino Salicylates
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Corticosteroids
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Immunomodulators
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Others
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  5. Global Crohn’s Disease Treatment Market, By Distribution Channel, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Segment Trends
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Hospitals
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  6. Global Crohn’s Disease Treatment Market, By Region, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Drugs Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  U.S.

Ø  Canada

    • Latin America
      • Market Size and Forecast (US$ Mn), By Drugs Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  Brazil

Ø  Mexico

Ø  Argentina and Chile   

Ø  Rest of Latin America

    • Europe
      • Market Size and Forecast (US$ Mn), By Drugs Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  Germany

Ø  UK

Ø  France

Ø  Russia

Ø  Italy

Ø  Switzerland

Ø  Sweden

Ø  Rest of Europe           

    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Drugs Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  China

Ø  India

Ø  Australia & New Zealand

Ø  Japan

Ø  South Korea

Ø  Rest of Asia Pacific

Ø  Rest of Asia Pacific

    • Middle East
      • Market Size and Forecast (US$ Mn), By Drugs Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  GCC

Ø  Israel

Ø  Saudi Arabia

Ø  UAE

Ø  Rest of Middle East

    • Africa
      • Market Size and Forecast (US$ Mn), By Drugs Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  North Africa

Ø  Central Africa

Ø  South Africa

  1. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Bayer AG

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • AbbVie Inc.

Ø  Company Overview

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • Janssen Biotech, Inc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • BoehringerIngelheim GmbH

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • Eli Lilly and Company

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • GlaxoSmithKline plc

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • Novartis International AG

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • Sanofi S.A.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • Allergan Inc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • Pfizer, Inc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • Takeda Pharmaceutical Company Limited

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • F. Hoffmann-La Roche

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • Bristol-Myers Squibb

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

    • Analyst Views
  1. Section
    • Research Methodology
    • About Us
    • Contact

FAQs

The crohn’s disease treatment market has been segmented on the basis of drug type, distribution channel, application, and region.

High prevalence of disease in key region such as U.S. is expected to increase demand for its treatment and drive market growth.

Lack of awareness and high cost of drug might hampers the market

Key players operating in the Crohn’s Disease Treatment market includes, AbbVie Inc., Janssen Biotech, Inc., BoehringerIngelheim GmbH, Eli Lilly and Company, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Allergan Inc., Pfizer, Inc.,Bayer AG, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche, and Bristol-Myers Squibb.

North America is expected to account major market share as compared to that of other regions.